Filing Details

Accession Number:
0001493152-16-010274
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-24 17:57:38
Reporting Period:
2016-05-24
Filing Date:
2016-05-24
Accepted Time:
2016-05-24 17:57:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1321834 Akers Biosciences Inc AKER In Vitro & In Vivo Diagnostic Substances (2835) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1661118 J John Gormally 80 Walsh Drive
Mahwah NJ 07430
Chief Executive Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-24 69 $2.19 69 No 4 P Direct
Common Stock Acquisiton 2016-05-24 1,000 $2.20 1,069 No 4 P Direct
Common Stock Acquisiton 2016-05-24 100 $2.23 1,169 No 4 P Direct
Common Stock Acquisiton 2016-05-24 1,131 $2.25 2,300 No 4 P Direct
Common Stock Acquisiton 2016-05-24 200 $2.24 2,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct